{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:22Z","timestamp":1790223382400,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.radonc.2021.06.027","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T03:18:39Z","timestamp":1624331919000},"page":"222-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities"],"prefix":"10.1016","volume":"161","author":[{"given":"Elton Trigo Teixeira","family":"Leite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Ramella","family":"Munhoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veridiana Pires de","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Guilherme Cernaglia Aureliano de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Cesar Seguel","family":"Rebolledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Eduardo Bravin","family":"Maistro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio de Freitas","family":"Busnardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio de Oliveira","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor","family":"Salvajoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heloisa de Andrade","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.06.027_b0005","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/annonc\/mdp415","article-title":"Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review","volume":"21","author":"Wibmer","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1996.14.3.859","article-title":"Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma","volume":"14","author":"Pisters","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.1998.16.1.197","article-title":"Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity","volume":"16","author":"Yang","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0020","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(02)09292-9","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial","volume":"359","author":"O'Sullivan","year":"2002","journal-title":"The Lancet"},{"key":"10.1016\/j.radonc.2021.06.027_b0025","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2002.03.084","article-title":"Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma","volume":"20","author":"Davis","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2004.12.020","article-title":"Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma","volume":"75","author":"Davis","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0035","doi-asserted-by":"crossref","first-page":"e507","DOI":"10.1016\/j.prro.2017.04.010","article-title":"Preoperative vs postoperative radiation therapy in localized soft tissue sarcoma: nationwide patterns of care and trends in utilization","volume":"7","author":"Lazarev","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0040","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1200\/JCO.2006.09.8525","article-title":"Evidence-based recommendations for local therapy for soft tissue sarcomas","volume":"25","author":"Pisters","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0045","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1259\/0007-1285-53-634-969","article-title":"Radiotherapy of liposarcomas","volume":"53","author":"Reitan","year":"1980","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.06.027_b0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2015.12.002","article-title":"Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies","volume":"119","author":"Haas","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0055","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0360-3016(86)90081-7","article-title":"Tumor radioresponsiveness versus fractionation sensitivity","volume":"12","author":"Thames","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.06.027_b0060","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1200\/JCO.2001.19.13.3203","article-title":"Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas","volume":"19","author":"Eilber","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1245\/ASO.2005.03.064","article-title":"Preoperative chemoradiotherapy (modified Eilber protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma","volume":"12","author":"Mack","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jso.20629","article-title":"Preoperative chemoradiation and flap reconstruction provide high local control and low wound complication rates for patients undergoing limb salvage surgery for upper extremity tumors","volume":"95","author":"Temple","year":"2007","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0075","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/cncr.23478","article-title":"Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas","volume":"112","author":"Ryan","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.06.027_b0080","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ijrobp.2009.03.015","article-title":"Primary tumor necrosis predicts distant control in locally advanced soft-tissue sarcomas after preoperative concurrent chemoradiotherapy","volume":"76","author":"MacDermed","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.06.027_b0085","doi-asserted-by":"crossref","first-page":"20130258","DOI":"10.1259\/bjr.20130258","article-title":"Hypofractionated adjuvant radiation therapy of soft-tissue sarcoma achieves excellent results in elderly patients","volume":"86","author":"Soyfer","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2021.06.027_b0090","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.ejso.2014.05.016","article-title":"Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas","volume":"40","author":"Kose\u0142a-Paterczyk","year":"2014","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"10.1016\/j.radonc.2021.06.027_b0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.06.027_b0100","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2021.06.027_b0105","first-page":"3911","article-title":"Complete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma","volume":"32","author":"Shah","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2021.06.027_b0110","series-title":"Common terminology criteria for adverse events (CTCAE) version 4.0","first-page":"03","author":"US Department of Health and Human Services","year":"2009"},{"key":"10.1016\/j.radonc.2021.06.027_b0115","series-title":"Sample size calculations in clinical research","first-page":"86","author":"Chow","year":"2008"},{"key":"10.1016\/j.radonc.2021.06.027_b0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.clon.2015.06.003","article-title":"Pathological response to preoperative treatment as a predictor of cancer outcome in the treatment of soft-tissue sarcoma","volume":"27","author":"Walshaw","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0125","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1245\/s10434-010-1156-3","article-title":"Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcoma","volume":"17","author":"Canter","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0130","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.bjps.2019.05.041","article-title":"Risk factors for postoperative wound complications after extremity soft tissue sarcoma resection: A systematic review and meta-analyses","volume":"72","author":"Slump","year":"2019","journal-title":"J Plastic Reconstr Aesth Surg"},{"key":"10.1016\/j.radonc.2021.06.027_b0135","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/cncr.27951","article-title":"Phase 2 study of preoperative image-guided intensity-modulated radiation therapy to reduce wound and combined modality morbidities in lower extremity soft tissue sarcoma","volume":"119","author":"O'Sullivan","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.06.027_b0140","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1200\/JCO.2014.58.5828","article-title":"Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of radiation therapy oncology group RTOG-0630 trial","volume":"33","author":"Wang","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0145","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.canrad.2018.05.009","article-title":"Effects of high-dose irradiation on vascularization: Physiopathology and clinical consequences","volume":"23","author":"Nivet","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2021.06.027_b0150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1126\/science.1088525","article-title":"Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking","volume":"302","author":"Dahan","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.radonc.2021.06.027_b0155","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1097\/COC.0000000000000443","article-title":"Long-term outcomes with ifosfamide-based hypofractionated preoperative chemoradiotherapy for extremity soft tissue sarcomas","volume":"41","author":"Pennington","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.06.027_b0160","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/COC.0000000000000236","article-title":"Preoperative radiosurgery for soft tissue sarcoma","volume":"41","author":"Kubicek","year":"2018","journal-title":"Am J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402106610X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402106610X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:18:09Z","timestamp":1759123089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402106610X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":32,"alternative-id":["S016781402106610X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.06.027","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}